retatrutide type 2 diabetes phase 2 lancet 2023 rosenstock Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Retatrutide (GLP-3) — Peptide Triple
Description
Eating smaller, lower-fat meals and staying hydrated usually resolve nausea within three to five days

Regardless of the requirements, your healthcare provider is your ally in the process and can help you navigate it and achieve your weight-loss goals

Among those with preexisting substance use disorders, GLP-1 takers had lower risks of hospitalization, overdose and suicidal ideation

Gilbert, P

Summary By eating more whole, unprocessed foods and exercising regularly, you will likely lose weight on the diet, especially if you stick to it long term
